BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)]. 1991

B Wyrzykowski, and K Suchecka-Rachoń
II Kliniki Chorób Wewnetrznych Instytutu Chorób Wewnetrznych Akademii Medycznej w Gdańsku.

In 35 patients with mild essential hypertension the influence of 9 week Viskaldix therapy on hemodynamics was evaluated. Twelve of them underwent repeated hemodynamic examinations after mean 13 months treatment. Viskaldix therapy lowered total peripheral resistance --TPR and there was no significant influence on the heart rate, stroke volume, and cardiac output. It was demonstrated that decrease of total peripheral resistance after treatment with Viskaldix was directly proportional to the initial values of TPR.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D003005 Clopamide A sulfamoylbenzamide piperidine. It is considered a thiazide-like diuretic. Brinaldix,Brinedine
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

B Wyrzykowski, and K Suchecka-Rachoń
Two-years' study with a combination of pindolol and clopamide ('Viskaldix') in patients with moderate hypertension.
January 1979, Current medical research and opinion,
B Wyrzykowski, and K Suchecka-Rachoń
A multi-centre general practice trial of a pindolol/clopamide combination ('Viskaldix') in essential hypertension.
January 1979, Current medical research and opinion,
B Wyrzykowski, and K Suchecka-Rachoń
[Pindolol-clopamide combination in the treatment of arterial hypertension. Clinical study].
January 1983, Therapie,
B Wyrzykowski, and K Suchecka-Rachoń
[Long-term study of a combination of pindolol and clopamide (Viskaldix Sandoz)].
January 1984, Lijecnicki vjesnik,
B Wyrzykowski, and K Suchecka-Rachoń
[Viskaldix for treatment of patients with moderate arterial hypertension. Comparative estimation of hemodynamic changes during treatment with Viskaldix and Stresson].
January 1986, Kardiologia polska,
B Wyrzykowski, and K Suchecka-Rachoń
[Hemodynamic effects of hydrochlorothiazide, propranolol and a combination of pindolol and clopamide in patients with essential hypertension].
May 1989, Revista espanola de cardiologia,
B Wyrzykowski, and K Suchecka-Rachoń
[Treatment of arterial hypertension with a combination of pindolol and clopamide in long-term use (personal experience)].
January 1984, Lijecnicki vjesnik,
B Wyrzykowski, and K Suchecka-Rachoń
[Treatment of hypertension with a fixed combination of pindolol and clopamide (VKB-105)].
January 1984, Lijecnicki vjesnik,
B Wyrzykowski, and K Suchecka-Rachoń
[Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
September 1981, Arquivos brasileiros de cardiologia,
B Wyrzykowski, and K Suchecka-Rachoń
[Treatment with Viskaldix in arterial hypertension].
January 1987, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
Copied contents to your clipboard!